Scientists will have new view into natural cell activity, accelerating drug development Madison, WI USA. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug […]
WALTHAM, Mass.—Olympus, a premier manufacturer of life science imaging systems and Ultivue, a leading developer of tissue biomarker identification and quantification assays for translational research, have entered into a comarketing agreement. The partnership will provide a comprehensive solution to the scientific community’s increasing need for fluorescent multiplexing. The recently launched Olympus SLIDEVIEW™ VS200 automated slider scanner […]
EnviroLogix Inc. offers first lateral flow test strip for the detection and quantification of aflatoxin and fumonisin in masa flour. Portland, ME, December 17, 2019 – EnviroLogix Inc. launched QuickTox Flex for the detection of aflatoxin and fumonisin in masa flour. QuickTox Flex is EnviroLogix’ state-of-the-art mycotoxin testing line of products designed for easy, accurate, […]
SOUTH SAN FRANCISCO — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and innovative research at the intersection of synthetic biology, protein engineering and personalized medicine, has chosen the Hyperion™ Imaging […]
Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products Seer, Inc., a life sciences company focused on capturing and translating proteome insights to advance human health, today announced it has raised $55 million in an oversubscribed Series D equity financing. The round was led by healthtech and life sciences […]
WELLESLEY, Mass., GARDNER, Mass. and LOUISVILLE, Ky. — Ampersand Capital Partners announced today that it has completed the acquisition of Peptides International and merged it with existing portfolio company New England Peptide. This merger brings together two leading providers of peptide synthesis services as well as a broad catalog of unique peptide products to assist in […]
SEATTLE — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M financing from new and existing investors. The funding will drive a global sales expansion for its instrument and consumables platform used in research […]
Consortium Plans to Apply Spatial Analysis to Major Challenges in Breast Cancer Research SEATTLE–(BUSINESS WIRE)–Dec. 11, 2019– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast Cancer Consortium (GBCC). The consortium is focused on using the GeoMx Digital Spatial Profiler to address some of the most challenging […]
LUND, Sweden–Genovis enzymes are used as platform methods in analytical workflows using mass spectrometry within the biopharma industry. Immobilized SialEXO benefits mass spectrometry but will significantly impact analytical workflows using capillary electrophoresis (CE). Charge variants of proteins are often analyzed using CE and the technology is well established for protein analysis and quality control. From our […]
SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an expanded antibody optimization collaboration with Pandion Therapeutics. Based on the successful completion of its first project for Pandion, Twist Biopharma, a division of Twist Bioscience, will apply […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
